The ‘off-label’ prescription of antidepressants to treat conditions for which they are not approved is on the rise. A nearly 10 year long McGill study, including 100,000+ prescriptions, has found that 29% of prescriptions are for off-label use. "Off-label' uses included insomnia, pain, & ADD/ADHD.

See the source article by following the link below:
The ‘off-label’ prescription of antidepressants to treat conditions for which they are not approved is on the rise. A nearly 10 year long McGill study, including 100,000+ prescriptions, has found that 29% of prescriptions are for off-label use. "Off-label' uses included insomnia, pain, & ADD/ADHD.